Pharmacology & ToxicologybioRxivPreprint
Vorapaxar and aripiprazole suppress hepatitis B virus replication through distinct host signaling pathways
Atsuya Yamashita, Hirotake Kasai, Haruyo Aoyagi…·Kohji Moriishi
This paper identifies vorapaxar and aripiprazole as inhibitors of HBV replication through distinct host signaling pathways, showing their potential as host-targeting antivirals.
DOI 10.64898/2026.08.05.743121